Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

JPMorgan strategists see European equities underperforming US peers for longer

Investing.com — JPMorgan strategists project that European equities will continue to underperform their US counterparts in 2025, as the group remains weighed down by subdued economic activity, political uncertainty, and structural headwinds.

Despite the eurozone’s underperformance, with the Euro Stoxx 50 index (SX5E) in a consolidation phase since March 2024, JPMorgan strategists believe the group “will be unable to advance in absolute terms for a while longer.” As a result, JPMorgan remains underweight European equities against the US.

The note highlights several key factors driving this outlook. Eurozone manufacturing PMIs remain weak, signaling sluggish industrial activity.

“Eurozone dataflow continues to lag the US and the trade uncertainty is likely to dampen International business confidence,” strategists led by Mislav Matejka said in a note.

Also, another key factor is the weakening topline growth, which JPMorgan highlights as a constraint for future earnings acceleration. The note warns that 2025 global EPS forecasts, projecting a 6% profit growth re-acceleration, are at risk of downgrades, “especially outside the US.” The eurozone’s projected 2025 earnings-per-share (EPS) growth of 10% is seen as “too optimistic” given the current environment, strategists stressed.

While the US has benefited from a stronger growth tilt, its valuations are notably higher, trading at a forward price-to-earnings ratio of 22x. By contrast, eurozone valuations appear cheaper but lack the earnings momentum to capitalize on this discount.

JPMorgan strategists also point to the impact of a strong US dollar and China’s underwhelming stimulus measures. These factors have disproportionately affected sectors with high eurozone exposure, such as autos, luxury goods, semiconductors, and chemicals, which the report advises investors to avoid.

Looking ahead, the strategists believe regional and style rotations might become more favorable in the second quarter of 2025. However, they caution that catalysts for a European recovery remain limited in the near term.

Beyond the US and the eurozone, JPMorgan remains Overweight on Japan and Neutral on the UK. In Japan, lower interest rates, accelerating buybacks, and improving wage growth support the positive outlook.

Meanwhile, the UK’s record valuation discount compared to other regions, coupled with the highest dividend yields globally, positions it as a more defensive option during periods of heightened market volatility.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com